FDA Greenlights New First-Line Regimen in Bladder Cancer Enfortumab vedotin plus pembrolizumab approved for cisplatin-ineligible patients Apr 04, 2023
Post-Immunotherapy Combo Promising in Advanced RCC Duration of response reaches 18.6 months with belzutifan plus cabozantinib Apr 03, 2023
VTE Risk in Recurrent Ovarian Cancer Increases With More Lines of Chemotherapy Prospective study in heavily treated population is warranted, researcher says Mar 30, 2023
Obesity's Impact on Uterine Cancer Risk Greater in Younger Age Groups Overall risk and risk of endometrioid subtype 20- to 30-fold greater in women younger than 35 Mar 30, 2023
A 'Double Whammy' for Gastric Cancer Risk H. pylori infection and certain pathogenic variants linked with large excess risk Mar 29, 2023
Phase III Trials 'Hit a Home Run' in Advanced Endometrial Cancer Adding immunotherapy will change frontline treatment, experts say Mar 28, 2023
Novel Strategies Show Winning Potential in Ovarian Cancer High response rates in small studies of immuno-oncology combination, neoadjuvant olaparib Mar 28, 2023
High Out-of-Pocket Costs Tied to Less Follow-Up After Initial Mammography Plans dominated by copays and deductibles are associated with higher out-of-pocket costs Mar 27, 2023
No Survival Benefit With CRT Versus Chemo for Locally Advanced Endometrial Cancer Long-running clinical trial failed to identify any subgroup that fared better with CRT Mar 27, 2023
FDA Greenlights First Drug for Rare Immunodeficiency Disease Activated PI3K-delta syndrome may have a new standard of care Mar 27, 2023
Make the Diagnosis: This Bump on His Nose is a Tricky Diagnosis A 52-year-old man visited his doctor for a new growth on his nose. Can you diagnosis the patient? Mar 27, 2023
CRT Regimen Boosts Complete Response Rate in Unresectable Vulvar Cancer Pathologic response rises to 73% versus 50% in historical control group Mar 27, 2023
CDK4/6 Inhibition Active in Recurrent Low-Grade Serous Ovarian Cancer Responses in a fourth of patients, clinical benefit in up to 90% Mar 26, 2023
Sam Neill's Rare Lymphoma The actor noticed swollen glands while on tour for "Jurassic World Dominion" Mar 23, 2023
Progestin-Only Birth Control Linked to Small Increase in Breast Cancer Risk But risk is similar to combined hormonal contraceptive use Mar 22, 2023
FDA OKs Another PD-1 Inhibitor for Merkel Cell Carcinoma Retifanlimab produced responses in 52% of patients with untreated unresectable disease Mar 22, 2023
Cancer Transmission From Organ Donors With Brain Tumors Not Much of a Risk In U.K. cohort study, no cases of transmission observed Mar 22, 2023
Sickle Cell Disease Patients Miss Out on Decades of Life What effects might emerging therapies have on real-world survival? Mar 17, 2023
FDA Allows Lower Risk Designation for Snuff Product The brand joins a limited few granted modified risk tobacco claims Mar 16, 2023
Laparoscopy, Surgery in a Draw for Gastric Cancer Survival Laparoscopy-assisted distal gastrectomy noninferior for both relapse-free, overall survival Mar 15, 2023
Take Risk Into Account Before Repeat Surveillance Colonoscopy, Study Says 58% of seniors with limited life expectancy, no significant findings invited for another round Mar 14, 2023
Novel PET Imaging Agent Accurately IDs Clear Cell Renal Cancers ZIRCON trial meets sensitivity and specificity targets Mar 13, 2023
FDA Panel Endorses New First-Line Lymphoma Regimen POLARIX trial supports a favorable risk-benefit profile for polatuzumab vedotin, ODAC members say Mar 10, 2023
Focus on Optimizing Use of CDK4/6 Inhibitors in Metastatic HR+ Breast Cancer Choice of agent, post-progression treatment, and resistance mechanisms top unanswered questions Mar 08, 2023
Understanding of HER2-Low Breast Cancer Continues to Evolve New breast cancer subtype proves challenging to define molecularly, pathologically, clinically Mar 07, 2023
FDA Not Quite Sold on Polivy in Frontline Large B-Cell Lymphoma Regimen Ahead of ODAC meeting, agency reviewers suggest modest PFS results in POLARIX "raise uncertainty" Mar 07, 2023
A Space for Mystery Elisha Waldman, MD, discusses faith and spirituality in medicine Mar 07, 2023 podcast
Full-Dose Anticoagulation Again Favored for COVID Admissions Despite failures, FREEDOM trial supports mortality advantage in general ward use Mar 07, 2023
KRAS Mutations in Metastatic CRC Predict Survival Benefit of Chemo Combo Trifluridine/tipiracil fails to improve survival in patients with KRAS G12-mutant tumors Mar 06, 2023
Cases of Breast Implant-Associated Lymphoma Continue to Accumulate More than 1,300 cases and 35 deaths, as reports of other implant-linked malignancies emerge Mar 06, 2023
'Our Goal Is Not to Omit Radiation Therapy' in Breast Cancer Honing indications for de-escalation of treatment intensity and, yes, selective omission of RT Mar 06, 2023
Antibody-Drug Conjugates Take Breast Cancer Field by Storm Established role in metastatic disease, may eventually replace chemotherapy Mar 04, 2023
Atorvastatin Tied to Cardioprotection for Lymphoma Patients on Anthracyclines STOP-CA deemed "an impactful study that will lead to more prescription of statins in patients." Mar 04, 2023
These Surgeries Made the Sharpest Turns to Outpatient Setting After COVID Several procedures saw significant increases in outpatient volumes Mar 03, 2023
'Winners' and 'Losers'; Mandated Sick Leave and Cancer Screening; More AI Advances News, features, and commentary about cancer-related issues Mar 03, 2023
Cancer-Free Medicare Recipients Received Fentanyl Indicated for Cancer Pain These prescriptions could lead to abuse, OIG report warns Mar 02, 2023
Vitamin B3 Doesn't Cut Skin Cancer Risk After Organ Transplant Randomized study finds no benefit with 12 months of nicotinamide versus placebo Mar 01, 2023
'Alarming' Rise in Colon Cancer Rates Among Younger People Rate doubled in under-50 age group since 1995, concerning trend toward more advanced disease Mar 01, 2023
How to Make Meaningful Moves Toward Health Equity in Cancer Care Addressing the three R's: resources, research, and racism Feb 27, 2023
